SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001193125-04-132816
Filing Date
2004-08-06
Accepted
2004-08-05 17:54:31
Documents
7
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE PERIOD ENDED JUNE 30, 2004. d10qsb.htm 10QSB 270678
2 SEPARATION, RETIREMENT AND CONSULTING AGREEMENT dex101.htm EX-10.1 24607
3 SEPARATION AGREEMENT dex10m.htm EX-10.(M) 22430
4 SECTION 302 CEO CERTIFICATION dex31a.htm EX-31.(A) 8600
5 SECTION 302 CFO CERTIFICATION dex31b.htm EX-31.(B) 8585
6 SECTION 906 CEO CERTIFICATION dex32a.htm EX-32.(A) 3324
7 SECTION 906 CFO CERTIFICATION dex32b.htm EX-32.(B) 3548
  Complete submission text file 0001193125-04-132816.txt   344264
Mailing Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217
Business Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217 5032833911
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-08092 | Film No.: 04955756
SIC: 2834 Pharmaceutical Preparations